<SEC-DOCUMENT>0001047469-17-000659-index.html : 20170214 <SEC-HEADER>0001047469-17-000659.hdr.sgml : 20170214 <ACCEPTANCE-DATETIME>20170214080207 ACCESSION NUMBER: 0001047469-17-000659 CONFORMED SUBMISSION TYPE: 424B5 PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20170214 DATE AS OF CHANGE: 20170214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NOVARTIS AG CENTRAL INDEX KEY: 0001114448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B5 SEC ACT: 1933 Act SEC FILE NUMBER: 333-207004 FILM NUMBER: 17602520 BUSINESS ADDRESS: STREET 1: LICHTSTRASSE 35 CITY: BASEL STATE: V8 ZIP: CH 4056 BUSINESS PHONE: 01141613241111 MAIL ADDRESS: STREET 1: LICHTSTRASSE 35 CITY: BASEL STATE: V8 ZIP: CH 4056 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Novartis Capital CORP CENTRAL INDEX KEY: 0001443411 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263086456 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B5 SEC ACT: 1933 Act SEC FILE NUMBER: 333-207004-02 FILM NUMBER: 17602521 BUSINESS ADDRESS: STREET 1: 608 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: (212)307 1122 MAIL ADDRESS: STREET 1: 608 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10020 </SEC-HEADER> <DOCUMENT> <TYPE>424B5 <SEQUENCE>1 <FILENAME>a2230897z424b5.htm <DESCRIPTION>PRELIMINARY PROSPECTUS SUPPLEMENT <TEXT> Document 1 - file: a2230897z424b5.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>g184809.jpg <DESCRIPTION>G184809.JPG <TEXT> Document 2 - file: g184809.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>g717681.jpg <DESCRIPTION>G717681.JPG <TEXT> Document 3 - file: g717681.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>g418586.jpg <DESCRIPTION>G418586.JPG <TEXT> Document 4 - file: g418586.jpg
</DOCUMENT> </SEC-DOCUMENT>